VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
APEI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
APEIAmerican Public Education, Inc.
$53.03$973M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAPEIFinancials

American Public Education, Inc. (APEI) Financials

22Y historyFree accessUpdated daily

Revenue growth has shown a modest recovery to 6.2% in 2026Q1, though operating margins remain sensitive to cost fluctuations, evidenced by a range between 1.5% and 12.5% over the last two years.

APEI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'03
Sales/Revenue659.05M648.86M624.56M600.54M606.33M418.8M321.79M286.27M297.69M299.25M313.14M327.91M350.02M329.48M313.52M260.38M198.17M149M107.15M69.09M40.05M28.18M17.76M
Revenue Growth %3.84%3.89%4%-0.95%44.78%30.15%12.41%-3.84%-0.52%-4.44%-4.5%-6.32%6.23%5.09%20.41%31.39%33%39.06%55.07%72.54%42.11%58.68%-
Cost of Goods Sold304.98M313.17M295.7M292.86M288.47M172.62M122.16M111.92M115.28M116.16M117.01M118.85M123.77M112.78M110.19M95.22M75.31M58.38M43.56M29.48M17.96M13.25M8.6M
COGS % of Revenue-48.26%47.35%48.77%47.58%41.22%37.96%39.09%38.73%38.82%37.37%36.24%35.36%34.23%35.15%36.57%38%39.18%40.66%42.66%44.85%47.01%48.45%
Gross Profit354.07M335.69M328.86M307.68M317.86M246.18M199.62M174.35M182.41M183.09M196.13M209.06M226.25M216.69M203.32M165.16M122.86M90.61M63.59M39.62M22.09M14.93M9.15M
Gross Margin %53.72%51.74%52.65%51.23%52.42%58.78%62.04%60.91%61.27%61.18%62.63%63.76%64.64%65.77%64.85%63.43%62%60.82%59.34%57.34%55.15%52.99%51.55%
Gross Profit Growth %-2.08%6.88%-3.2%29.11%23.32%14.49%-4.41%-0.37%-6.65%-6.19%-7.6%4.41%6.58%23.11%34.42%35.59%42.51%60.51%79.37%47.92%63.09%-
Operating Expenses296.49M281.83M295.79M355.99M455.2M215.81M174.87M153.71M149M146.13M147.15M156.78M160.42M149.26M134.52M102.3M72.84M50.75M37.9M24.93M19.15M12.71M7.31M
OpEx % of Revenue-43.44%47.36%59.28%75.08%51.53%54.34%53.69%50.05%48.83%46.99%47.81%45.83%45.3%42.91%39.29%36.76%34.06%35.37%36.07%47.81%45.1%41.15%
Selling, General & Admin284.38M281.83M270.77M261.19M275M196.7M161.03M138.11M131.5M127.36M127.76M136.26M144.3M135.75M123.38M93.06M66.34M45.52M33.66M22.1M14.04M11.41M2.82M
SG&A % of Revenue-43.44%43.35%43.49%45.36%46.97%50.04%48.24%44.17%42.56%40.8%41.55%41.23%41.2%39.35%35.74%33.48%30.55%31.42%31.98%35.07%40.48%15.86%
Research & Development00000000000000000000000
R&D % of Revenue-----------------------
Other Operating Expenses2M025.02M94.8M180.2M19.11M13.84M15.6M17.5M18.78M19.38M20.52M16.12M13.51M11.15M9.24M6.5M5.23M4.24M2.83M5.1M1.3M4.49M
Operating Income57.57M53.86M33.07M-48.31M-137.35M30.37M24.76M28.54M33.41M34.86M38.28M52.28M65.83M67.44M68.8M62.86M50.02M39.87M25.69M14.69M2.94M2.22M1.85M
Operating Margin %8.74%8.3%5.29%-8.04%-22.65%7.25%7.69%9.97%11.22%11.65%12.22%15.94%18.81%20.47%21.95%24.14%25.24%26.76%23.97%21.26%7.34%7.89%10.41%
Operating Income Growth %-62.89%168.45%64.83%-552.23%22.68%-13.26%-14.57%-4.16%-8.93%-26.79%-20.58%-2.38%-1.98%9.45%25.66%25.48%55.19%74.86%399.69%32.19%20.35%-
EBITDA73.88M70.01M52.37M-20.49M-105.22M48.2M37.74M44.14M50.91M53.63M57.66M72.8M81.95M80.94M79.95M72.1M56.52M45.1M29.92M17.52M4.89M3.52M2.06M
EBITDA Margin %11.21%10.79%8.38%-3.41%-17.35%11.51%11.73%15.42%17.1%17.92%18.41%22.2%23.41%24.57%25.5%27.69%28.52%30.27%27.93%25.35%12.22%12.51%11.62%
EBITDA Growth %26.74%33.68%355.58%80.53%-318.29%27.72%-14.49%-13.3%-5.08%-6.98%-20.8%-11.17%1.25%1.25%10.89%27.55%25.34%50.71%70.83%257.98%38.85%70.74%-
D&A (Non-Cash Add-back)16.31M16.15M19.3M27.82M32.13M17.83M12.98M15.6M17.5M18.78M19.38M20.52M16.12M13.51M11.15M9.24M6.5M5.23M4.24M2.83M1.95M1.3M216K
EBIT57.61M53.86M33.07M-48.31M-133.52M30.37M25.61M20.65M33.41M36.95M48.98M53.1M65.95M67.75M68.94M62.86M50.02M39.87M25.69M14.69M2.94M2.22M1.85M
Net Interest Income-4.07M-4.23M-2.13M-4.46M-17.73M-4.28M1.09M3.91M2.92M185K116K115K361K309K135K109K111K94K706K888K289K225K0
Interest Income0000001.09M3.91M2.92M185K116K115K361K309K135K109K111K94K706K888K289K225K0
Interest Expense4.07M4.23M2.13M4.46M17.73M4.28M00000000000000000
Other Income/Expense-5.98M-10.15M-2.13M-9.7M-13.92M-5.11M1.09M-3.98M2.03M185K116K115K361K309K135K109K111K94K706K888K289K225K5K
Pretax Income51.59M43.7M30.94M-58M-151.27M25.26M25.85M16.66M35.44M35.04M38.39M52.4M66.19M67.75M68.94M62.97M50.13M39.96M26.39M15.58M3.23M2.45M1.85M
Pretax Margin %7.83%6.74%4.95%-9.66%-24.95%6.03%8.03%5.82%11.91%11.71%12.26%15.98%18.91%20.56%21.99%24.18%25.3%26.82%24.63%22.55%8.06%8.69%10.43%
Income Tax11.2M12.15M10.42M-10.71M-36.28M7.51M7.02M5.19M9.29M11.49M14.94M20.07M25.15M25.64M26.53M22.21M20.27M16.02M10.21M6.83M771K1.06M634K
Effective Tax Rate %21.7%27.8%33.68%18.47%23.98%29.73%27.16%31.13%26.2%32.8%38.91%38.31%37.99%37.85%38.48%35.27%40.42%40.08%38.67%43.83%23.88%43.32%34.21%
Net Income40.4M31.56M16.11M-47.29M-114.99M17.75M18.82M10.01M25.64M21.12M24.16M32.41M40.88M42.03M42.32M40.76M29.87M23.94M16.19M8.75M1.8M1.08M217K
Net Margin %6.13%4.86%2.58%-7.87%-18.97%4.24%5.85%3.5%8.61%7.06%7.71%9.88%11.68%12.76%13.5%15.65%15.07%16.07%15.11%12.66%4.49%3.85%1.22%
Net Income Growth %64.94%95.85%134.08%58.88%-747.77%-5.68%87.98%-60.95%21.39%-12.56%-25.48%-20.7%-2.75%-0.68%3.84%36.46%24.75%47.91%84.99%386.65%65.71%400%-
Net Income (Continuing)40.4M31.56M20.52M-47.29M-114.99M17.75M18.82M10.01M25.64M21.12M24.16M32.41M40.88M42.03M42.32M40.76M29.87M23.94M16.19M8.75M2.46M1.39M1.22M
Discontinued Operations00000000000000000000000
Minority Interest00000000000000000000000
EPS (Diluted)2.151.360.55-2.94-6.080.971.250.621.541.291.491.932.332.352.352.231.591.270.860.640.15-1.440.04
EPS Growth %87.33%147.27%118.71%51.64%-726.8%-22.4%101.61%-59.74%19.38%-13.42%-22.8%-17.17%-0.85%0%5.38%40.25%25.2%47.67%34.38%326.67%110.42%-3700%-
EPS (Basic)-1.400.57-2.94-6.100.981.270.621.561.301.501.942.362.382.382.281.631.320.910.690.15-1.440.04
Diluted Shares Outstanding18.8M18.66M18.15M18.19M18.91M18.25M15.05M16.25M16.63M16.38M16.21M16.8M17.54M17.92M18.04M18.3M18.84M18.91M18.82M13.6M12.18M8.06M5.4M
Basic Shares Outstanding18.28M18.01M17.63M18.11M18.86M18.09M14.88M16.09M16.4M16.24M16.07M16.68M17.36M17.66M17.77M17.88M18.28M18.17M17.84M12.76M11.74M8.06M5.4M
Dividend Payout Ratio-------------------1071.43%---

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Regulatory and Enrollment Volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Shows Modest Recovery

According to recent financial disclosures, APEI's revenue growth has fluctuated, reaching 6.2% in 2026Q1 after a period of contraction in late 2025, suggesting that the company's efforts to stabilize enrollment across its core APUS and nursing segments are beginning to yield early, albeit inconsistent, top-line results.

The recent return to positive year-over-year growth suggests that the company may be successfully navigating the post-acquisition integration challenges of Rasmussen University. However, investors should monitor whether this growth is driven by sustainable enrollment gains or temporary pricing adjustments, as the competitive landscape in nursing education remains intense.

Operating Margin Volatility Remains Elevated

As reported in quarterly filings, APEI's operating margins have exhibited significant volatility, ranging from a low of 1.5% in 2024Q2 to 12.5% in 2026Q1, indicating that the company's cost structure remains highly sensitive to fluctuations in student acquisition costs and faculty wage inflation within its nursing programs.

The wide variance in operating margins suggests that the company lacks the structural cost flexibility to maintain consistent profitability during periods of shifting enrollment. The reliance on high-touch, campus-based nursing programs appears to be a primary drag on margin stability compared to the more scalable online APUS model.

Operating Leverage Remains Under Pressure

Based on the provided income statement data, APEI's operating income has struggled to scale proportionally with gross profit, as evidenced by the 2025Q3 period where gross profit of $88.5M yielded only $9.7M in operating income, highlighting the heavy burden of fixed SG&A expenses on the bottom line.

The inability to consistently leverage operating expenses suggests that the company's administrative and marketing overhead is not yet optimized for its current revenue scale. Future margin expansion will likely depend on management's ability to control SG&A growth while simultaneously driving higher enrollment density across its existing campus footprint.

Structural Risks to Margin Sustainability

Analysis of the income statement reveals that despite recent improvements, APEI's net margins remain thin at 10.1% in 2026Q1, which may indicate that the company's business model is vulnerable to any further increases in regulatory compliance costs or competitive pressure on tuition pricing in the nursing sector.

Short-term profitability gains may be masking underlying structural weaknesses, particularly the high cost of maintaining physical nursing labs and clinical partnerships. Investors should remain cautious, as any disruption to the Title IV funding pipeline or a decline in NCLEX-RN pass rates could rapidly reverse recent earnings momentum.

APEI — Frequently Asked Questions

Quick answers to the most common questions about buying APEI stock.

What was American Public Education, Inc.'s (APEI) revenue in 2025?

For fiscal year 2025, American Public Education, Inc. (APEI) reported total revenue of $648.9M. This represents a 3553.9% increase compared to $17.8M in 2003.

Is American Public Education, Inc. (APEI) profitable?

American Public Education, Inc. (APEI) is profitable, generating $31.6M in net income for the fiscal year ending 2025 with a net profit margin of 4.9%.

What is American Public Education, Inc.'s operating profit margin?

American Public Education, Inc. (APEI) reported an operating income of $53.9M, resulting in an operating profit margin of 8.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is American Public Education, Inc.'s gross profit and gross margin?

American Public Education, Inc. (APEI) generated $335.7M in gross profit for the year, representing a gross profit margin of 51.7%. This demonstrates the company's core pricing power and production efficiency.